| 注册
首页|期刊导航|医学信息|德拉马尼上市后研究项目药品全流程管理模式探索

德拉马尼上市后研究项目药品全流程管理模式探索

旷琛 蔡翠

医学信息2024,Vol.37Issue(1):35-40,6.
医学信息2024,Vol.37Issue(1):35-40,6.DOI:10.3969/j.issn.1006-1959.2024.01.006

德拉马尼上市后研究项目药品全流程管理模式探索

Exploration of the Whole Process Management Mode of Drug in the Post Marketing Research Project of Delamanid

旷琛 1蔡翠2

作者信息

  • 1. 贵阳市公共卫生救治中心药剂科,贵州 贵阳 550003
  • 2. 贵阳市公共卫生救治中心结核病诊疗质控中心,贵州 贵阳 550003
  • 折叠

摘要

Abstract

In this paper,the circulation and use of drugs in the post-marketing research project of Delamani are controlled in an all-round way from the three links of project drug management,group management and pharmaceutical care,so as to ensure the quality of drugs and the correctness of the process of receiving and distributing,the matching degree and compliance of patients and projects,and the real-time recording of related drug treatment and adverse reactions,so that the details of drug use can be traced back.While conforming to the project management norms,the scientific management methods of patients'medication links were further explored to ensure the safety and effectiveness of patients'medication norms.

关键词

德拉马尼/项目药品全流程管理/药学监护

Key words

Delamanid/Whole process management of project drugs/Pharmaceutical monitoring

分类

药学

引用本文复制引用

旷琛,蔡翠..德拉马尼上市后研究项目药品全流程管理模式探索[J].医学信息,2024,37(1):35-40,6.

医学信息

1006-1959

访问量0
|
下载量0
段落导航相关论文